Mucosal and systemic HIV-1 Env-specific CD8 + T-cells develop after intragastric vaccination with a Salmonella Env DNA vaccine vector

By Shata M.T.   Reitz Jr. M.S.   DeVico A.L.   Lewis G.K.   Hone D.M.  

Vaccine, Vol. 20, Iss. 3, 2001-11 ,pp. : 623-629

Elsevier

Access to resources Recommend Favorite

DNA vaccination followed by macromolecular multicomponent peptide vaccination against HIV-1 induces strong antigen-specific immunity

By Okuda K.   Xin K.-Q.   Tsuji T.   Bukawa H.   Tanaka S.-i.   Koff W.C.   Tani K.   Okuda K.   Honma K.   Kawamoto S.   Hamajima K.   Fukushima J.  

Vaccine, Vol. 15, Iss. 10, 1997-07 ,pp. : 1049-1056

Elsevier

Access to resources Recommend Favorite

Specific passive immunity reduces the excretion of glycoprotein E-negative bovine herpesvirus type 1 vaccine strain in calves

By Lemaire M.   Hanon E.   Schynts F.   Meyer G.   Thiry E.  

Vaccine, Vol. 19, Iss. 9, 2000-12 ,pp. : 1013-1017

Elsevier

Access to resources Recommend Favorite

Chimeras between the human immunodeficiency virus (HIV-1) Env and vaccinia virus immunogenic proteins p14 and p39 generate in mice broadly reactive antibodies and specific activation of CD8+ T cell responses to Env

By Collado  

Vaccine, Vol. 18, Iss. 27, 2000-07 ,pp. : 3123-3133

Elsevier

Access to resources Recommend Favorite

A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. II. Induction of TH1 and TH2 responses in mice

By Babai I.   Samira S.   Barenholz Y.   Zakay-Rones Z.   Kedar E.  

Vaccine, Vol. 17, Iss. 9, 1999-03 ,pp. : 1239-1250

Elsevier

Access to resources Recommend Favorite